← Back to Search

Other

VSJ-110 for Dry Eye

Phase 2
Recruiting
Research Sponsored by Vanda Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured over a 4-week treatment period

Summary

This trial aims to find out if a new medication called VSJ-110 is safe and effective in treating dry eye compared to a placebo.

Who is the study for?
This trial is for adults over 18 years old with dry eye syndrome who can follow the study's instructions and attend all visits. Participants must consent to the study rules and privacy regulations. Those using certain medications that are not allowed during the trial cannot participate.
What is being tested?
The trial is testing VSJ-110, a potential new treatment for dry eye, against a placebo (a substance with no therapeutic effect). The goal is to see if VSJ-110 is safe and works better than taking nothing at all.
What are the potential side effects?
While specific side effects of VSJ-110 aren't listed here, common side effects in trials like this may include temporary discomfort or irritation in the eyes, redness, blurred vision, or watery eyes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured over a 4-week treatment period
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured over a 4-week treatment period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Schirmer's Tear Test
Secondary study objectives
Eye Dryness Score (EDS) of the Visual Analogue Scale (VAS)
Ocular Staining

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: VSJ-110 SolutionExperimental Treatment1 Intervention
Group II: Placebo SolutionPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VSJ-110
2020
Completed Phase 2
~50

Find a Location

Who is running the clinical trial?

Vanda PharmaceuticalsLead Sponsor
62 Previous Clinical Trials
19,390 Total Patients Enrolled
~24 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top